Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The carried forward losses wouldn't be material in any negotiations, since they are not debt that has to be paid back to anyone. They were funded by the shareholders (groans at the predictable response to that fact). Any selling price could only reflect the potential selling power of the product going forwards. That's not easy to asses because Fruitflow has never been in the hands of a consumer brand with the promotional power to make it a household name. By Health do have that power, they have proved that with some of their other products. they have the financial clout, they have the consumer base. Dr Asim clearly believes that more health claims may be developed given the funding, releasing yet more sales potential. I'd be pleased with either of the figures mentioned, but don't think the commercial mood will be conducive to anything happening short term.
Kievsky
I hope you are right, I think are losses are nearer 25£MM, 1.25p, ps though
W$
Wellsite, IMO we will not go for less than 5p. We have spent over 1million to get where we are. I will continue to top when I can and if the price is ok. Strong buy here. Blue cap must be close
morning All
Behind the scenes,'medical' negotiations are buzzing(despite the economy)-the world's populations need/deserve medical interventions-& fast.
Hopefully DSM & By-Health are realising what theyve got (pxs's FF)...& more importantly,doing something about it.
stay safe.
You may want to think of the bigger picture at this time. Talk of takeover seems to me to be inappropriate. The more likely candidate has been a Chinese company, since they have been prime movers in acquiring health related companies globally. To me, it seems unlikely that a return to business in the same pre Covid way will happen. A greatly weakened world economy would surely put the brakes on expansionary thinking for a fairly long time.
I do agree that the stock options of directors would have a bearing on the thoughts of those conducting negotiations, I just don't think there will be any such negotiations until the business world sorts itself out.
Kievsky
The thing is we have never had sight of a business plan, with targets and milestones, so we have no idea what “ PXS coming good” actually means. Let’s assume IF wants to make a million from FF, then, due to his large (excessive?) number of stock options then the SP need only go to 2.3p. Not sure of the tax on the options, so scale up accordingly. This puts FF worth 46 mill. What is the”coming good” figure you have in mind
.W£
Fully understand the frustration with lack of news from the top. Yes Gixer does great work in finding out all his snippets. As IF said in the last few RNS we are given small snippets on the bi-health situation and as he said we are lucky as a company to be given just these from bi-health. No news is good news at the moment. Will be interesting if we get info on llyoyds selling fruitflow plus and whether warrants an RNS or just put on our web page. Stuart Lucas is still and adding in previous times in the last 12 months so that has to be a good sign. Hold strong all. I am sur PXS will come good. And yes I agree it's been a bloody long and frustrating wait.
Glad someone agrees with me on that. What a doddle it must be to "run" this tiny unimpressive company.
CB
Tend to agree re communication, without Gixer we would know diddly squat and I’m sure the SP would be in the decimal teens
W$
The Pope.
Recruited by who?
WS. A proactive and enthusiastic approach will never happen under the current regime. This is the AIM gravy train. I would like to see wholesale change and a certain ineffective person kicked out and replaced by someone with communication skills and vision.
I saw a transit up at Silverstone fly tipping! I now wonder who’s transit it was.
Alf
To me it is irrelevant whether FF is a food supplement or a fully paid up medicine. It is worth evaluating ...
W$
If I follow your line of thinking, I'd better get on and prepare my Transit 3.5 tonner for an entry in the Silverstone Grand Prix.
Strewth. Never let plain facts get in the way of another childish snipe ehh.
Right on cue, the chief apologist responds.
"Anyone who thinks a dietary supplement could claim medical efficacy is barmy IMHO."
Ah, right. Now I understand why the medical profession has zero interest in Fruitflow. I also now understand why DSM & PXS make no effort to promote the benefits of Fruitflow and why more funds will probably need to be raised in the near future due to lack of interest by prospective wholesalers.
Alf, thanks for the clarification.
Anyone who thinks a dietary supplement could claim medical efficacy is barmy IMHO.
It couldn't even be commercially suggested unless trials on Covid patients had been conducted, and the chances of that are remote. Yes, it has anti inflammatory claims, and we know that any virus causes inflammation, beyond that is in the fevered minds of straw clutchers. many, many other natural products have similar anti inflammatory properties. Blood smoothing is a valuable property, but it couldn't be prescribed by those treating Covid. Because it isn't a medicine, isn't on the NICE list, and has zero test data against that virus.
To the best of my knowledge, Provexis have made absolutely no attempt to allude to the benefits of good blood flow and anti - clotting properties and relevance to Covid 19.Before the usual suspect attacks me, DSM have experts who should have been more proactive even in the face of a moribund BOD.
GC
I don't think it’s mercenary to expect the company to be pushing FF if there is the remotest chance it could help....
A few of my friends have started taking FF because of the outbreak. One had tried it before but stopped taking it because of the cost.
Well disappointed$
I hate to be mercenary about this but our product can clearly help here. We (the company) really need to make our suppliers aware so they can ramp up delivery capability.
Is it? Depends how you look at it........
Both lloyds pharmacy and holland and Barrett are out of stock. Good sign !!!
"Associate Professor Senanayake said advice to consider blood thinners in COVID-19 treatment had already been put out to doctors internationally. At Dr Oxley's hospital, Mount Sinai, internal guidelines had been updated overnight, instructing staff to put all COVID-19 patients entering intensive care on powerful blood thinners."
There’s been numerous cases in the news about it over last few weeks:
https://www.google.com.au/amp/s/amp.smh.com.au/national/opera-singer-among-those-hit-by-covid-19-blood-clot-mystery-20200428-p54nts.html
Cannot verify of substantsiate but thought i'd share someone's summary on another board,of interview regarding Covid
autopsies:
"unexpected blood clotting occurring in patients,in paticular in the lungs(but also occurring elsewhere)-&
they believe this clotting is preventing the lungs from absorbing oxygen,leading to dramatic declines in
patient outcomes"
Please DYOR ,but thought interesting.